CA2659246C - Novel engineered microorganism producing homo-succinic acid and method for preparing succinic acid using the same - Google Patents
Novel engineered microorganism producing homo-succinic acid and method for preparing succinic acid using the same Download PDFInfo
- Publication number
- CA2659246C CA2659246C CA2659246A CA2659246A CA2659246C CA 2659246 C CA2659246 C CA 2659246C CA 2659246 A CA2659246 A CA 2659246A CA 2659246 A CA2659246 A CA 2659246A CA 2659246 C CA2659246 C CA 2659246C
- Authority
- CA
- Canada
- Prior art keywords
- succinic acid
- producing
- gene
- bacterial mutant
- organic acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/44—Polycarboxylic acids
- C12P7/46—Dicarboxylic acids having four or less carbon atoms, e.g. fumaric acid, maleic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1217—Phosphotransferases with a carboxyl group as acceptor (2.7.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y203/00—Acyltransferases (2.3)
- C12Y203/01—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
- C12Y203/01054—Formate C-acetyltransferase (2.3.1.54), i.e. pyruvate formate-lyase or PFL
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The present invention relates to a rumen bacterial mutant producing homo- succinic acid and a method for producing homo-succinic acid using the same, and more particularly to a rumen bacterial mutant producing succinic acid at a high concentration while producing little or no other organic acids in anaerobic conditions, which is obtained by disrupting a gene encoding lactate dehydrogenase (idhA), a gene encoding phosphotransacetylase (pta), and a gene encoding acetate kinase (ackA), without disrupting a gene encoding pyruvate formate lyase (p.beta.), as well as a method for producing succinic acid using the same. The inventive rumen bacterial mutant has the property of having a high growth rate and succinic acid productivity while producing little or no organic acids, as compared to the prior strains producing succinic acid. Thus, the inventive rumen bacterial mutant is useful to produce succinic acid for industrial use.
Description
NOVEL ENGINEERED MICROORGANISM PRODUCING HOMO-SUCCINIC ACID AND METHOD FOR PREPARING SUCCINIC
ACID USING THE SAME
TECHNICAL FIELD
The present invention relates to a rumen bacterial mutant producing homo-succinic acid and a method for preparing homo-succinic acid using the same, and more particularly to a rumen bacterial mutant producing succinic acid at high concentration while producing little or no other organic acids in anaerobic conditions, which is obtained by disrupting a gene encoding lactate dehydrogenase (ldhA), a gene encoding phosphotransacetylase (pta), and a gene encoding acetate kinase (ackA), without disrupting a gene encoding pyruvate formate lyase (pfl), as well as a method for preparing succinic acids using the same.
BACKGROUND ART
Succinic acid (HOOCCH2CH2COOH), a dicarboxylic acid consisting of 4 carbons, is an organic acid having high utilities, which is widely used as a precursor of medicine, food, cosmetics, and chemical products of other industries (Zeikus et al., Appl. Microbiol. Biotechnol., 51:545, 1999; Song et al., Enzyme Microbial Technol., 39:352, 2006). Particularly, the demand for succinic acid is expected to be dramatically increased as a main source of biodegradable macromolecules, with the latest sharp increase in petroleum prices (Willke et al., Appl.
Microbiol.
Biotechnol., 66:131, 2004).
Succinic acid can be produced by chemical synthesis and fermentation. However, most of succinic acid for industrial use is currently produced through chemical synthesis methods using n-butane and acetylene derived from petroleum as a raw material by Chinese chemical companies, Japanese chemical companies, and big Chemical companies such as BASF, DuPont, BP chemical etc., but only a small amount of succinic acid for special use such as medicine etc. is produced by traditional microbial fermentation method. The above-mentioned chemical synthesis methods have a problem of discharging large amounts of hazardous waste, effluent, and waste gas (e.g., CO, etc.) generated during a process of producing succinic acid. Particularly, fossil fuels having high possibility of being exhausted are used as basic material, and thus there is an urgent need to develop a method for preparing succinic acids to replace the fossil fuels with alternative fuels such as renewable resources.
To overcome these problems caused by the chemical synthesis process for preparing succinic acid, studies on producing succinic acids by microbial fermentation using various renewable resources have been intensively and widely conducted by many researchers. Microorganisms, which have been used in succinic acid production, vary, but they can be generally classified into recombinant Escherichia. coli and ruminal bacteria (Actinobacillus, Anaerobiospirillum, Bacteroides, Mannheimia, Succinimonas, Succinivibrio, etc.) (Song et al., Enzyme Microbial Technol., 39:352, 2006).
Among studies on producing succinic acids using recombinant E.coli, there was an attempt to increase succinic acid production by preparing a mutant AFP111 (ATCC No. 202021) obtained through a method in which a glucose transport gene (ptsG) is manipulated while genes (ldh and pfl), which are involved in producing lactic acid and formic acid in E.coli, are eliminated, by the University of Chicago research team (U.S. patent No. 5,770,435).
The present inventors have amplified a malic enzyme gene (sfcA) involved in succinic acid production, in recombinant E.coli, NZN1 11 strain, from which ldh
ACID USING THE SAME
TECHNICAL FIELD
The present invention relates to a rumen bacterial mutant producing homo-succinic acid and a method for preparing homo-succinic acid using the same, and more particularly to a rumen bacterial mutant producing succinic acid at high concentration while producing little or no other organic acids in anaerobic conditions, which is obtained by disrupting a gene encoding lactate dehydrogenase (ldhA), a gene encoding phosphotransacetylase (pta), and a gene encoding acetate kinase (ackA), without disrupting a gene encoding pyruvate formate lyase (pfl), as well as a method for preparing succinic acids using the same.
BACKGROUND ART
Succinic acid (HOOCCH2CH2COOH), a dicarboxylic acid consisting of 4 carbons, is an organic acid having high utilities, which is widely used as a precursor of medicine, food, cosmetics, and chemical products of other industries (Zeikus et al., Appl. Microbiol. Biotechnol., 51:545, 1999; Song et al., Enzyme Microbial Technol., 39:352, 2006). Particularly, the demand for succinic acid is expected to be dramatically increased as a main source of biodegradable macromolecules, with the latest sharp increase in petroleum prices (Willke et al., Appl.
Microbiol.
Biotechnol., 66:131, 2004).
Succinic acid can be produced by chemical synthesis and fermentation. However, most of succinic acid for industrial use is currently produced through chemical synthesis methods using n-butane and acetylene derived from petroleum as a raw material by Chinese chemical companies, Japanese chemical companies, and big Chemical companies such as BASF, DuPont, BP chemical etc., but only a small amount of succinic acid for special use such as medicine etc. is produced by traditional microbial fermentation method. The above-mentioned chemical synthesis methods have a problem of discharging large amounts of hazardous waste, effluent, and waste gas (e.g., CO, etc.) generated during a process of producing succinic acid. Particularly, fossil fuels having high possibility of being exhausted are used as basic material, and thus there is an urgent need to develop a method for preparing succinic acids to replace the fossil fuels with alternative fuels such as renewable resources.
To overcome these problems caused by the chemical synthesis process for preparing succinic acid, studies on producing succinic acids by microbial fermentation using various renewable resources have been intensively and widely conducted by many researchers. Microorganisms, which have been used in succinic acid production, vary, but they can be generally classified into recombinant Escherichia. coli and ruminal bacteria (Actinobacillus, Anaerobiospirillum, Bacteroides, Mannheimia, Succinimonas, Succinivibrio, etc.) (Song et al., Enzyme Microbial Technol., 39:352, 2006).
Among studies on producing succinic acids using recombinant E.coli, there was an attempt to increase succinic acid production by preparing a mutant AFP111 (ATCC No. 202021) obtained through a method in which a glucose transport gene (ptsG) is manipulated while genes (ldh and pfl), which are involved in producing lactic acid and formic acid in E.coli, are eliminated, by the University of Chicago research team (U.S. patent No. 5,770,435).
The present inventors have amplified a malic enzyme gene (sfcA) involved in succinic acid production, in recombinant E.coli, NZN1 11 strain, from which ldh
2 and pfl genes are eliminated, to suppress pyruvic acid accumulated in the fermentation process of the NZN111 strain, thus increasing succinic acid production (Hong et al., Biotechnol. Bioeng., 74:89, 2001). Also, a Georgia University-led team of researchers has constructed an AFP111/pTrc99A pyc strain by expressing a pyruvate carboxylase gene (pyc) in the AFP 111 strain, and then used this strain in producing succinic acid (Vemuri et al., J. Ind. Microbiol.
Biotechnol., 28:325, 2001). Recently, in order to induce the production of succinic acid in anaerobic conditions, a Rice University-led team of researchers reported that they have constructed recombinant E.coli strains by manipulating genes involved in pathways of Glycolysis, TCA cycle, and Glyoxylate (Lin et al., Eng., 7:116, 2005; Lin et al., Biotechnol. Bioeng., 90:775, 2005).
Actinobacillus strain, Anaerobiospirillum strain, and Mannheimia strain, which are a kind of rumen bacteria, are known to be excellent in producing succinic acid, so that studies on the strains have been actively conducted. Michigan Biotechnology Institute (MBI)-led team of researchers in America discovered Actinobacillus succinogenes 130Z strain (ATCC No.55618) to develop a method for producing succinic acid, and constructed various mutant strains of Actinobacillus succinogenes, using traditional chemical mutagenesis to use in developing a process for producing and purifying succinic acid (U.S. patent No.
5,521,075; U.S. patent No. 5,168,055; U.S. patent No. 5,143,834).
However, succinic acid production process using microbial fermentation, developed until now, has a very low productivity of less than 2g/L/h, and especially it incures a huge cost to separate and purify succinic acid because succinic acid is produced together with large amounts of various organic acids and ethanol as byproducts to some degree during fermentation. Although the above-mentioned results showed an effect of decreasing lactic acid, formic acid, acetic acid, and ethanol as byproducts in some recombinant strains, they did not show complete elimination of them. In addition, in another recombinant mutant
Biotechnol., 28:325, 2001). Recently, in order to induce the production of succinic acid in anaerobic conditions, a Rice University-led team of researchers reported that they have constructed recombinant E.coli strains by manipulating genes involved in pathways of Glycolysis, TCA cycle, and Glyoxylate (Lin et al., Eng., 7:116, 2005; Lin et al., Biotechnol. Bioeng., 90:775, 2005).
Actinobacillus strain, Anaerobiospirillum strain, and Mannheimia strain, which are a kind of rumen bacteria, are known to be excellent in producing succinic acid, so that studies on the strains have been actively conducted. Michigan Biotechnology Institute (MBI)-led team of researchers in America discovered Actinobacillus succinogenes 130Z strain (ATCC No.55618) to develop a method for producing succinic acid, and constructed various mutant strains of Actinobacillus succinogenes, using traditional chemical mutagenesis to use in developing a process for producing and purifying succinic acid (U.S. patent No.
5,521,075; U.S. patent No. 5,168,055; U.S. patent No. 5,143,834).
However, succinic acid production process using microbial fermentation, developed until now, has a very low productivity of less than 2g/L/h, and especially it incures a huge cost to separate and purify succinic acid because succinic acid is produced together with large amounts of various organic acids and ethanol as byproducts to some degree during fermentation. Although the above-mentioned results showed an effect of decreasing lactic acid, formic acid, acetic acid, and ethanol as byproducts in some recombinant strains, they did not show complete elimination of them. In addition, in another recombinant mutant
3 strains, there were some cases where the growth rates of them have become so low that overall succinic acid productivity was not increased. Therefore, there is an urgent demand to develop a novel succinic acid-producing strain, which has a high productivity of succinic acid and prevents the production of byproducts (Hong et al., Biotechnol. Lett., 22:871, 2000).
To develop a novel succinic acid-producing strain to satisfy the above demands, isolation of a strain having excellent succinic acid productivity, completion of genome sequence thereof, an understanding of metabolic characteristic thereof, and establishing a genetic manipulation technique required for the construction of a recombinant strain should be preceded. Up to now, in the case of rumen bacteria having high succinic acid productivity, the full genome sequence of strain M.
succiniciproducens MBEL 55E was completed, but those of rumen bacteria such as Actinobacillus, Anaerobiospirillum etc. have not been reported yet.
Although an attempt to try to produce succinic acids by amplifying phosphoenolpyruvate carboxykinase gene (pckA) of A. succinogenes and A. succiniciproducens in E.coli, has been reported (Kim et al., Appl. Environ. Microbiol., 70:1238, 2004;
Laivenieks et al., Appl. Environ. Microbiol., 63:2273, 1997), there has been no attempt to try to develop a recombinant succinic acid production strain based on genome sequence.
The present inventors have reported that they isolated M. succiniciproducens MBEL 55E (KCTC0769BP) producing succinic acid with high efficiency from Korean native cattle, and completed genome sequence and charaterized metabolic properties of the strain (Hong et al., Nature Biotechnol., 22:1275, 2004).
Also, the present inventors have constructed a bacterial mutant, M.succiniciproducens LPK (KCTC10558BP) by disrupting a gene encoding lactate dehydrogenase (ldhA) and a gene encoding pyruvate formate-lyase (pfl) in M.
succiniciproducens MBEL 55E which is a kind of rumen bacteria in order to inhibit the production of lactic acids and formic acids. In addition to that, the present inventions have
To develop a novel succinic acid-producing strain to satisfy the above demands, isolation of a strain having excellent succinic acid productivity, completion of genome sequence thereof, an understanding of metabolic characteristic thereof, and establishing a genetic manipulation technique required for the construction of a recombinant strain should be preceded. Up to now, in the case of rumen bacteria having high succinic acid productivity, the full genome sequence of strain M.
succiniciproducens MBEL 55E was completed, but those of rumen bacteria such as Actinobacillus, Anaerobiospirillum etc. have not been reported yet.
Although an attempt to try to produce succinic acids by amplifying phosphoenolpyruvate carboxykinase gene (pckA) of A. succinogenes and A. succiniciproducens in E.coli, has been reported (Kim et al., Appl. Environ. Microbiol., 70:1238, 2004;
Laivenieks et al., Appl. Environ. Microbiol., 63:2273, 1997), there has been no attempt to try to develop a recombinant succinic acid production strain based on genome sequence.
The present inventors have reported that they isolated M. succiniciproducens MBEL 55E (KCTC0769BP) producing succinic acid with high efficiency from Korean native cattle, and completed genome sequence and charaterized metabolic properties of the strain (Hong et al., Nature Biotechnol., 22:1275, 2004).
Also, the present inventors have constructed a bacterial mutant, M.succiniciproducens LPK (KCTC10558BP) by disrupting a gene encoding lactate dehydrogenase (ldhA) and a gene encoding pyruvate formate-lyase (pfl) in M.
succiniciproducens MBEL 55E which is a kind of rumen bacteria in order to inhibit the production of lactic acids and formic acids. In addition to that, the present inventions have
4
5 PCT/KR2007/003574 constructed a mutant M.succiniciproducens LPK7 (KCTC1062BP) by disrupting a phosphotransacetylase gene (pta) and an acetate kinase gene (ackA) in the mutant strain, M.succiniciproducens LPK in order to inhibit the production of acetic acid, to culture the bacterial mutants in anaerobic conditions (WO
05/052135 Al; Lee et al., Appl. Environ. Microbiol. 72:1939, 2006), thus increasing succinic acid. However, in case of such mutant strains, although the production of byproducts, formic acid and acetic acid could be suppressed to some extent, a large amonut of pyruvic acids were accumulated as a byproduct during fermentation, most of all, the growth rate of the strain has become so low compared with a wild strain that an excellect succinic acid productivity could not be achieved.
Meanwhile, it was reported that a pyruvate formate-lyase gene (pfl) participates in conversion of pyruvic acid into acetyl Coenzyme A (acetyl-CoA), thus affecting cell growth and redistribution of pyruvic acid (Wolfe, Microbial. Mol. Biol.
Rev., 69:12, 2005).
Accordingly, the present inventors have made extensive efforts to construct a mutant microorganism capable of producing homo-succinic acids at a high yield by minimizing a decrease in microbial growth rate and completely inhibiting the formation of various byproducts including pyruvic acids and to develop a fermentation method thereof, and as a result, they have constructed a bacterial mutant M. succiniciproducens PALK (KCTC10973BP) by disrupting a lactate dehydrogenase gene (ldhA), a phosphotransacetylase gene (pta), and an acetate kinase gene (ackA) without disrupting a pyruvate formate-lyase gene (pfl) in M.
succiniciproducens MBEL55E which is a kind of rumen bacteria, and then fermentated the mutant strain in anaerobic conditions using glucose and glycerol as carbon sources, and confirmed that the mutant strain can produce nearly homo-succinic acid at a high yield, thereby completing the present invention.
SUMMARY OF THE INVENTION
Therefore, it is an object of the present invention to provide a mutant microorganism that has high growth rate and succinic acid productivity and produces only succinic acid at a high yield while producing little or no other organic acids during the period of anaerobic fermentation.
Another object of the present invention is to provide a method for producing homo-succinic acid without the accumulation of other byproducts, by culturing the mutant microorganism using glucose and glycerol as carbon sources in anaerobic conditions.
To achieve the above objects, the present invention provides a rumen bacterial mutant lacking a lactate dehydrogenase gene (ldhA), a phosphotransacetylase gene (pta), and an acetate kinase gene (ackA) in a microorganism producing succinic acid while only a pyruvate formate-lyase gene (pfl) is maintained in the microorganism producing succinic acid, which has the property of producing only succinic acid at high concentration while producing little or no other organic acids in anaerobic conditions.
Also, the present invention provides a rumen bacterial mutant Mannhimia succinicproducens PALK (KCTC10973BP) lacking a lactate dehydrogenase gene (ldhA), a phosphotransacetylase gene (pta), and an acetate kinase gene (ackA) in M. succiniciproducens while a pyruvate formate-lyase gene (pfl) is maintained in M. succiniciproducens, which has the property of producing succinic acid at high concentration while producing little or no other organic acids in anaerobic conditions.
Additionally, the present invention provides a method for producing a mutant microorganism, the method comprising the steps of: (a) obtaining a rumen
05/052135 Al; Lee et al., Appl. Environ. Microbiol. 72:1939, 2006), thus increasing succinic acid. However, in case of such mutant strains, although the production of byproducts, formic acid and acetic acid could be suppressed to some extent, a large amonut of pyruvic acids were accumulated as a byproduct during fermentation, most of all, the growth rate of the strain has become so low compared with a wild strain that an excellect succinic acid productivity could not be achieved.
Meanwhile, it was reported that a pyruvate formate-lyase gene (pfl) participates in conversion of pyruvic acid into acetyl Coenzyme A (acetyl-CoA), thus affecting cell growth and redistribution of pyruvic acid (Wolfe, Microbial. Mol. Biol.
Rev., 69:12, 2005).
Accordingly, the present inventors have made extensive efforts to construct a mutant microorganism capable of producing homo-succinic acids at a high yield by minimizing a decrease in microbial growth rate and completely inhibiting the formation of various byproducts including pyruvic acids and to develop a fermentation method thereof, and as a result, they have constructed a bacterial mutant M. succiniciproducens PALK (KCTC10973BP) by disrupting a lactate dehydrogenase gene (ldhA), a phosphotransacetylase gene (pta), and an acetate kinase gene (ackA) without disrupting a pyruvate formate-lyase gene (pfl) in M.
succiniciproducens MBEL55E which is a kind of rumen bacteria, and then fermentated the mutant strain in anaerobic conditions using glucose and glycerol as carbon sources, and confirmed that the mutant strain can produce nearly homo-succinic acid at a high yield, thereby completing the present invention.
SUMMARY OF THE INVENTION
Therefore, it is an object of the present invention to provide a mutant microorganism that has high growth rate and succinic acid productivity and produces only succinic acid at a high yield while producing little or no other organic acids during the period of anaerobic fermentation.
Another object of the present invention is to provide a method for producing homo-succinic acid without the accumulation of other byproducts, by culturing the mutant microorganism using glucose and glycerol as carbon sources in anaerobic conditions.
To achieve the above objects, the present invention provides a rumen bacterial mutant lacking a lactate dehydrogenase gene (ldhA), a phosphotransacetylase gene (pta), and an acetate kinase gene (ackA) in a microorganism producing succinic acid while only a pyruvate formate-lyase gene (pfl) is maintained in the microorganism producing succinic acid, which has the property of producing only succinic acid at high concentration while producing little or no other organic acids in anaerobic conditions.
Also, the present invention provides a rumen bacterial mutant Mannhimia succinicproducens PALK (KCTC10973BP) lacking a lactate dehydrogenase gene (ldhA), a phosphotransacetylase gene (pta), and an acetate kinase gene (ackA) in M. succiniciproducens while a pyruvate formate-lyase gene (pfl) is maintained in M. succiniciproducens, which has the property of producing succinic acid at high concentration while producing little or no other organic acids in anaerobic conditions.
Additionally, the present invention provides a method for producing a mutant microorganism, the method comprising the steps of: (a) obtaining a rumen
6 bacterial mutant lacking the gene encoding lactate dehydrogenase (ldhA) by disrupting a gene encoding lactate dehydrogenase (ldhA) from the genome of succinic acid producing rumen bacteria using homologous recombination; and (b) obtaining a rumen bacterial mutant lacking a gene encoding lactate dehydrogenase (ldhA), a gene encoding phosphotransacetylase (pta), and a gene encoding acetate kinase (ackA) by disrupting a gene encoding phosphotransacetylase (pta) and a gene encoding acetate kinase (ackA), from the genome of the rumen bacterial mutant lacking the gene encoding lactate dehydrogenase (ldhA), by homologous recombination.
Further, the present invention provides a method for producing succinic acid, the method comprising the steps of: culturing the rumen bacterial mutants in anaerobic conditions; and recovering succinic acid from the culture broth.
Another features and embodiments of the present invention will be more clarified from the following detailed descriptions and the appended claims.
BRIEF DESCRIPTION OF DRAWINGS
FIG. 1 is a schematic diagram showing the succinic acid production pathway in the mutant microorganism according to the present invention.
FIG. 2 shows a process of constructing a replacement vector for disrupting ldhA
(pMLKO-sacB) by homologous recombination.
FIG. 3 shows a process of constructing a bacterial mutant (M.
succinicproducens LK) by disrupting ldhA gene in Mannheimia succiniciproducens MBEL55E by homologous recombination.
Further, the present invention provides a method for producing succinic acid, the method comprising the steps of: culturing the rumen bacterial mutants in anaerobic conditions; and recovering succinic acid from the culture broth.
Another features and embodiments of the present invention will be more clarified from the following detailed descriptions and the appended claims.
BRIEF DESCRIPTION OF DRAWINGS
FIG. 1 is a schematic diagram showing the succinic acid production pathway in the mutant microorganism according to the present invention.
FIG. 2 shows a process of constructing a replacement vector for disrupting ldhA
(pMLKO-sacB) by homologous recombination.
FIG. 3 shows a process of constructing a bacterial mutant (M.
succinicproducens LK) by disrupting ldhA gene in Mannheimia succiniciproducens MBEL55E by homologous recombination.
7 FIG. 4 shows a process of constructing a replacement vector for disrupting pta and ackA (pPTA-sacB) by homologous recombination.
FIG. 5 shows a process of constructing a bacterial mutant (M.
succinicproducens PALK) by disrupting ldhA and pta-ackA genes in M. succiniciproducens LK by homologous recombination.
FIG. 6 is an electrophoresis photograph showing the disruption of pta-ackA in M.
succiniciproducens PALK, wherein M represents lkb marker; lanes 1-6 represent PCR fragments (1.1 kb) using primers, PAUl and SP1; lanes A-F represent PCR
fragments (1.5 kb) using primers, SP2 and PAD2.
FIG. 7 shows the culture characteristics of the inventive M.
succiniciproducens PALK in anaerobic conditions saturated with CO2.
DETAILED DESCRIPTION OF THE INVENTION, AND
PREFERRED EMBODIMENTS
In one aspect, the present invention relates to a rumen bacterial mutant lacking a lactate dehydrogenase gene (ldhA), a phosphotransacetylase gene (pta), and an acetate kinase gene (ackA) in a microorganism producing succinic acid while only a pyruvate formate-lyase gene (pfl) is maintained in the microorganism producing succinic acid, which has the property of producing only succinic acid at a high concentration while producing little or no other organic acids in anaerobic conditions.
In the present invention, the succinic acid-producing microorganism refers to a microorganism capable of producing an excessive large amount of succinic acid compared to the production of ethanol or other organic acids, which can be used for industrial use in succinic acid production by fermentation.
FIG. 5 shows a process of constructing a bacterial mutant (M.
succinicproducens PALK) by disrupting ldhA and pta-ackA genes in M. succiniciproducens LK by homologous recombination.
FIG. 6 is an electrophoresis photograph showing the disruption of pta-ackA in M.
succiniciproducens PALK, wherein M represents lkb marker; lanes 1-6 represent PCR fragments (1.1 kb) using primers, PAUl and SP1; lanes A-F represent PCR
fragments (1.5 kb) using primers, SP2 and PAD2.
FIG. 7 shows the culture characteristics of the inventive M.
succiniciproducens PALK in anaerobic conditions saturated with CO2.
DETAILED DESCRIPTION OF THE INVENTION, AND
PREFERRED EMBODIMENTS
In one aspect, the present invention relates to a rumen bacterial mutant lacking a lactate dehydrogenase gene (ldhA), a phosphotransacetylase gene (pta), and an acetate kinase gene (ackA) in a microorganism producing succinic acid while only a pyruvate formate-lyase gene (pfl) is maintained in the microorganism producing succinic acid, which has the property of producing only succinic acid at a high concentration while producing little or no other organic acids in anaerobic conditions.
In the present invention, the succinic acid-producing microorganism refers to a microorganism capable of producing an excessive large amount of succinic acid compared to the production of ethanol or other organic acids, which can be used for industrial use in succinic acid production by fermentation.
8 Typical succinic acid-producing microorganisms include rumen bacteria. From partial genetic information (16s rRNA), enzyme analysis, and fermentation results of Actinobacillus succinogenes, Anaerobiospirillum succiniciproducens which are a kind of rumen bacteria, and various rumen bacteria which are known to produce succinic acid until now, it was found that main biosynthesis pathway for succinic acid production from a carbon source in rumen bacteria is almost identical with biosynthesis pathway for succinic acid production in Mannheimia sp. which is a kind of rumen bacteria (Table 1; Van der Werf et al., Arch Microbiol., 167:332, 1997; Laivenieks et al., Appl. Environ. Microbiol., 63:2273, 1997; Samuelov et al., App. Environ. Microbiol., 65:2260, 1999; Kim et al., Appl.
Environ. Microbiol., 70:1238, 2004). Especially all rumen bacteria, which is involved in the production of succinic acid, convert phosphoenolpyruvate and pyruvate, C3 compounds into oxaloacetate and malate, C4 compounds using C02-fixing enzyme upon succinic acid production, thus producing succinic acid. In addition, rumen bacteria produce acetic acid, formic acid, and lactic acid as fermentation byproducts in anaerobic conditions, thus suggesting that all rumen bacteria including the Mannheimia sp. have the same pathway for succinic acid biosynthesis.
Table 1 Succinic acid producing rumen bacteria Strain References Cytophaga succinicans Anderson et al., J. Bacteriol., 81:130, 1961 Fibrobacter succinogens Wood et al., J. Cereal. Sci., 19:65, 1994 Ruminococcus flavefaciens lannotti et al., Appl. Environ. Microbiol., 43:136, Succinimonas am lol tica Bryant, Bacteriol. Rev., 23:125, 1959 Succinivibrio dextrinisolvens Bryant, Bacteriol. Rev., 23:125, 1959 Actinobacillus succinogenes Glutter et al., Int. J. Syst. Bacteriol., 49:207, Mannheimia succiniciproducens Hong et al., Nature Biotechnol., 22:1275, 2004
Environ. Microbiol., 70:1238, 2004). Especially all rumen bacteria, which is involved in the production of succinic acid, convert phosphoenolpyruvate and pyruvate, C3 compounds into oxaloacetate and malate, C4 compounds using C02-fixing enzyme upon succinic acid production, thus producing succinic acid. In addition, rumen bacteria produce acetic acid, formic acid, and lactic acid as fermentation byproducts in anaerobic conditions, thus suggesting that all rumen bacteria including the Mannheimia sp. have the same pathway for succinic acid biosynthesis.
Table 1 Succinic acid producing rumen bacteria Strain References Cytophaga succinicans Anderson et al., J. Bacteriol., 81:130, 1961 Fibrobacter succinogens Wood et al., J. Cereal. Sci., 19:65, 1994 Ruminococcus flavefaciens lannotti et al., Appl. Environ. Microbiol., 43:136, Succinimonas am lol tica Bryant, Bacteriol. Rev., 23:125, 1959 Succinivibrio dextrinisolvens Bryant, Bacteriol. Rev., 23:125, 1959 Actinobacillus succinogenes Glutter et al., Int. J. Syst. Bacteriol., 49:207, Mannheimia succiniciproducens Hong et al., Nature Biotechnol., 22:1275, 2004
9 In the present invention, a succinic acid-producing mutant microorganism with a high growth rate, which is capable of producing succinic acid at a high concentration while producing little or no other organic acids, was constructed by manipulating the genome of rumen bacteria which is a succinic acid-producing microorganism. In other words, a lactate dehydrogenase gene (ldhA), a phosphotransacetylase gene (pta), and an acetate kinase gene (ackA) were disrupted in the genome DNA of M. succiniciproducens MBEL55E
(KCTC0769BP), thereby constructing a bacterial mutant M. succiniciproducens PALK (KCTC 10973BP) which shows a high growth rate and produces succinic acid at a high concentration while producing little or no other organic acids.
In the present invention, for the disruption of each gene, a method of substituting the genes by homologous recombination to inactivate was used, but any method can be used without limitations as long as it is genetic manipulation method where the corresponding gene can be modified or eliminated, such that an enzyme encoded by the corredponding gene is not generated.
In the present invention, the rumen bacteria are selected from the group consisting of Mannheimia sp., Actinobacillus sp. and Anaerobiospirillum sp.
In the present invention, the mutant microorganism is preferably a homogeneous fermentation strain producing only succinic acid while forming little or no other organic acids as byproducts, the amounts of other organic acids produced are preferably less than lwt% based on the amount of succinic acid produced, and the other organic acids are preferably any one or more organic acids selected from the group consisting of lactic acid, acetic acid, formic acid, and pyruvic acid.
In another aspect, the present invention relates to a rumen bacterial mutant M.
succiniciproducens PALK (KCTC10973BP), lacking a lactate dehydrogenase gene (ldhA), a phosphotransacetylase gene (pta), and an acetate kinase gene (ackA) in M. succiniciproducens while a pyruvate formate-lyase gene (pfl) is maintained in M. succiniciproducens, which has the property of producing succinic acid at a high concentration while producing little or no other organic acids in anaerobic conditions.
The bacterial mutant M. succiniciproducens LPK7 (KCTC10626BP), which was constructed by disrupting a gene encoding lactate dehydrogenase (ldhA), a gene encoding pyruvate formate-lyase (pfl), a gene encoding phosphotransacetylase (pta), and a gene encoding acetate kinase (ackA) in the genome of Mannheimia sp., was used in order to compare the succinic acid productivity and growth rate of M. succiniciproducens PALK (KCTC10973BP) according to the present invention with those of traditional bacterial mutants. Herein, the bacterial mutant M. succiniciproducens LPK7 (KCTC 10626BP) has an additional disruption of a gene encoding pyruvate formate-lyase (pfl) in the mutant strain M.
succiniciproducens PALK (KCTC10973BP) according to the present invention (W02005/052135; Lee et al., Appl. Environ. Microbiol. 72:1939, 2006).
M. succiniciproducens PALK (KCTC10973BP) according to the present invention has a high succinic acid productivity and produces little or no byproducts such as lactic acid, acetic acid, formic acid, and pyruvic acid, thus showing excellent properties compared to wild-type M. succiniciproducens MBEL55E
(KCTC0769BP) for succinic acid production and previously constructed bacterial mutant M. succiniciproducens LPK7 (KCTC10626BP), and can produce succinic acid at a high yields due to a high growth rate thereof, high succinic acid productivity and homo-succinic acid production by preventing pyruvic acid accumulation, compared to previously constructed bacterial mutant M.
succiniciproducens LPK7 (KCTC 10626BP).
In still another aspect, the present invention relates to a method for constructing a mutant microorganism, the method comprising the steps of: (a) obtaining a rumen bacterial mutant lacking a gene encoding lactate dehydrogenase (ldhA) by disrupting a gene encoding lactate dehydrogenase (ldhA) in genome of succinic acid producing rumen bacteria using homologous recombination; and (b) obtaining a rumen bacterial mutant lacking a gene encoding lactate dehydrogenase (ldhA), a gene encoding phosphotransacetylase (pta), and a gene encoding acetate kinase (ackA) by disrupting a gene encoding phosphotransacetylase (pta) and a gene encoding acetate kinase (ackA) in genome of the rumen bacterial mutant lacking a gene encoding lactate dehydrogenase (ldhA) by homologous recombination,.
In the present invention, the homologous recombination of the step (a) is preferably performed using a genetic exchange vector containing a disrupted ldhA, and the homologous recombination of the step (b) is preferably performed using a genetic exchange vector containing a disrupted pta-ackA.
In the present invention, the genetic exchange vector containing a disrupted ldhA
is preferably pMLKO-sacB, and the genetic exchange vector containing a disrupted pta-ackA is preferably pMPKO-sacB.
The present invention also provides a method for producing succinic acid, the method comprising the steps of: culturing the above-mentioned mutant microorganism in anaerobic conditions; and recovering succinic acid from the culture broth.
In the present invention, for the culture, glucose or glycerol is preferably used as a carbon source, and the amounts of other organic acids produced as byproducts are preferably less than 1 wt% based on the amount of succinic acid produced.
In yet another aspect, the present invention relates to a method for preparing succinic acid, the method comprising the steps of: culturing the rumen bacterial mutant in anaerobic conditions; and recovering succinic acid from the culture broth.
The culture of the succinic acid producing mutant microorganism according to the present invention and recovery process of succinic acid can be performed by the culture methods known in the conventional fermentation process and methods for separating and purifying succinic acid.
In the present invention, for the culture, glucose or glycerol is preferably used as a carbon source, and the amounts of other organic acids produced as byproducts are preferably less than 1 wt% based on the amount of succinic acid produced.
Examples The present invention will hereinafter be described in further details by examples.
It will however be obvious to a person skilled in the art that these examples are given for illustrative purpose only, and the present invention is not limited to or by the examples.
Particularly, the following examples illustrate only Mannheimia sp. which is a succinic acid-producing microorganism as a host cell in order to delete the genes according to the present invention. However, it is obvious to a person skilled in the art that a mutant microorganism producing homo-succinic acid can be obtained even when other kinds of succinic acid producing microorganisms are used.
Example 1: Construction of ldhA disruption vector (pMLKO-sacB) In order to disrupt a lactate dehydrogenase gene (ldhA) in the genome of a succinic acid-producing microorganism by homologous recombination, a gene exchange vector was constructed in the following manner. First, the genomic DNA of M. succiniciproducens MBEL55E (KCTC 0769BP), as a template, was subjected to PCR using primers set forth in SEQ ID NO: 1 and SEQ ID NO: 2 below, and then, the obtained PCR fragment containing ldhA-homologous region 1 (L1) was cut with SacI and Pstl and introduced into pUC 18 vector (New England Biolabs, Inc., USA), thereby constructing pUC18-L1.
SEQ ID NO: 1: 5'-CAGTGAAGGAGCTCCGTAACGCATCCGCCG
SEQ ID NO: 2: 5'-CTTTATCGAATCTGCAGGCGGTTTCCAAAA
In addition, the genomic DNA of M. succiniciproducens MBEL55E (KCTC
0769BP), as a template, was subjected to PCR using primers set forth in SEQ ID
NO: 3 and SEQ ID NO: 4 below, and then, the obtained PCR fragment containing ldhA-homologous region 2 (L2) was cut with Pstl and HindIII and introduced into the pUC 18-L 1, thereby constructing pUC 18-L 1-L2.
SEQ ID NO: 3: 5'-GTACTGTAAACTGCAGCTTTCATAGTTAGC
SEQ ID NO: 4: 5'-GCCGAAAGTCAAGCTTGCCGTCGTTTAGTG
In order to insert kanamycin-resistant gene as a selection marker in the pUC
L1-L2, pUC4K vector (Pharmacia, Germany) was cut with Pstl, and the resulting kanamycin-resistant gene was fused with pUC18-L1-L2 cut with PstI, thereby constructing pUC 18-L 1-KmR-L2. A linker set forth in SEQ ID NO: 5 was inserted into the pUC 18-L 1-KmR-L2 cut with SacI, thereby making a new Xbal cutting site.
SEQ ID NO: 5: 5'-TCTAGAAGCT
In order to insert sacB gene in the pUC18-L1- KmR-L2 into which the Xbal cutting site has been inserted, PCR on pKmobsacB (Schafer et al., Gene, 145:69, 1994) as a template was performed using primers set forth in SEQ ID NO: 6 and 7.
Then the resulting PCR fragment containing sacB gene was cut with Xbal, and inserted into the new XbaI restriction enzyme site of pUC18-L1-KmR-L2 into which the above Xbal cutting site has been inserted, thereby constructing pMLKO-sacB, an exchange vector for disrupting ldhA gene (FIG. 2).
SEQ ID NO: 6: 5'-GCTCTAGACCTTCTATCGCCTTCTTGACG
SEQ ID NO: 7: 5'-GCTCTAGAGGCTACAAAATCACGGGCGTC
Example 2: Construction of M. succiniciproducens LK strain A mutant strain was constructed by disrupting ldhA gene in the genome of M.
succiniciproducens MBEL55E (KCTC0769BP) using pMLKO-sacB constructed in Example 1 as a genetic exchange vector for disrupting ldhA gene (FIG. 3).
In other words, M. succiniciproducens MBEL55E (KCTC0769BP) was plated on LB-glucose agar medium containing 10 g/L of glucose, and cultured at 37 C for 36 hours. The colony formed was inoculated in 10 ml of LB-glucose liquid medium, and cultured for 12 hours. 1% of the culture broth, which had been sufficiently grown, was inoculated in 100 ml of LB-glucose liquid medium, and cultured in a shaking incubator at 200 rpm and 37 C.
When the culture broth reached an OD600 of about 0.3-0.4 after 4-5hours, it was centrifuged at 4 C and 4,500 rpm for 20 minutes to collect cells. Then, the cells were resuspended in 200 ml of 10% glycerol solution at 4 C. The suspension was centrifuged at 4 C and 5,500 rpm for 20 minutes, and the cells were collected.
After resuspending and collecting in one-half of the above glycerol solution twice in the same manner as the above-described processes, the cells were suspended in glycerol at a volume ratio of 1:1, to obtain cell concentrate.
The cell concentrate thus obtained was mixed with the genetic exchange vector pMLKO-sacB constructed in Example 1, and then pMLKO-sacB was introduced into the cultured M. succiniciproducens MBEL55E (KCTC0769BP) by electroporation under conditions of 1.8 kV, 25 F and 200 ohms. 1 ml of LB-glucose liquid medium was added to the pMLKO-sacB-introduced strain, and precultured in a shaking incubator at 37 C and 200rpm for one hour. The culture broth was plated on LB-glucose solid medium containing an antibiotic kanamycin (final concentration of 25 g/ml) and cultured at 37 C for 48 hours or more.
In order to select a colony where only double crossover occurred, the colonies formed were streaked on LB-sucrose solid medium containing kanamycin (25 g/ml) and 100g/L sucrose. After 24 hours, the formed colonies were streaked again on the same medium.
The colonise (mutant) formed on the medium were cultured in LB-glucose liquid medium containing an antibiotic, and genomic DNA was isolated from the cultured strain by the method described in Rochelle et al. (Rochelle et al., FEMS
Microbiol. Lett., 100:59, 1992). PCR was performed using the isolated mutant genomic DNA as a template, and the PCR product was electrophoresed to confirm the disruption of ldhA gene in the genomic DNA.
In order to confirm the disruption of the ldhA gene, PCRs were performed twice in the following manners. First, the mutant genomic DNA as a template was subjected to PCR using primers set forth in SEQ ID NO: 8 and SEQ ID NO: 9.
SEQ ID NO: 8: 5'-GACGTTTCCCGTTGAATATGGC (KM1) SEQ ID NO: 9: 5'-CATTGAGGCGTATTATCAGGAAAC (LU1) Then, the mutant genomic DNA as a template was subjected to PCR using primers set forth in SEQ ID NO: 10 and SEQ ID NO: 11.
SEQ ID NO: 10: 5'-GCAGTTTCATTTGATGCTCGATG (KM2) SEQ ID NO: 11: 5'-CCTCTTACGATGACGCATCTTTCC (LD2) The PCR fragments obtained in the two PCRs were subjected to gel electrophoresis to confirm the disruption of ldhA by their size. The PCR
fragments of the genomic DNA having disrupted ldhA were confirmed by the fact that the product resulted from the PCR using the primers of SEQ ID NO: 8 (KM
1) and SEQ ID NO: 9(LU1) has a size of 1.5 kb, and at the same time the product resulted from the PCR using the primers of SEQ ID NO: 10 (KM2) and SEQ ID
NO: 11 (LU2) has a size of 1.7 kb. The position of each primer is shown in FIG. 3.
The mutant strain M. succiniciproducens LK was constructed by disrupting ldhA
gene in the genome of M. succiniciproducens MBEL55E according to the above method.
Example 3: Construction of gene exchange vector (pPTA-sacB) for the disruption of pta and ackA
In order to disrupt pta and ackA in the genome of M. succinicproducens LK
strain by homologous recombination, a genetic exchange vector was constructed in the following manner. A vector pKmobsacB containing a sacB gene, as a template, was subjected to PCR using primers set forth in SEQ ID NO: 12 and SEQ ID NO:
13. The resulting sacB product was cut with Pstl and BamHI and inserted into pUC19 (Stratagene Cloning Systems. USA), thereby constructing pUC19-sacB
(FIG 4).
SEQ ID NO: 12: 5'-AGCGGATCCCCTTCTATCGCCTTCTTGACG
SEQ ID NO: 13: 5'-GTCCTGCAGGGCTACAAAATCACGGGCGTC
Meanwhile, the genomic DNA of M. succiniciproducens LK as a template was subjected to PCR using primers set forth in SEQ ID NO: 14 and SEQ ID NO: 15, and the resulting PCR fragment containing pta-ackA homologous region 1 was cut with Xbal and BamH1. In addition, the genomic DNA of M.
succiniciproducens LK as a template was subjected to PCR using primers set forth in SEQ ID NO: 16 and SEQ ID NO: 17, and the resulting PCR fragment containing pta-ackA homologous region 2 was cut with Xbal and SacI. Then, these fragments were inserted into BamHI and SacI site of pUC19, thereby constructing pUC 19-PTA 12.
SEQ ID NO: 14: 5'-GCTCTAGATATCCGCAGTATCACTTTCTGCGC
SEQ ID NO: 15: 5'-TCCGCAGTCGGATCCGGGTTAACCGCACAG
SEQ ID NO: 16: 5'-GGGGAGCTCGCTAACTTAGCTTCTAAAGGCCA
TGTTTCC
SEQ ID NO: 17: 5'-GCTCTAGATATCCGGGTCAATATCGCCGCAAC
In order to insert a spectinomycin-resistant gene (GenBank X02588; SpR) as a selective marker in pUC19-PTA12, plasmid pIC156 (Steinmetz et al., Gene, 142:79, 1994) containing a spectinomycin-resistant gene (GenBank X02588), as a template, was subjected to PCR using primers set forth in SEQ ID NO: 18 and SEQ ID NO: 19, and the resulting PCR fragment containing SpR gene was cut with EcoRV and introduced into the pUC 19-PTA12, thereby constructing pUC 19-PTAl S2 having the spectinomycin-resistant gene. The constructed pUC 19-PTA1S2 was cut with SacI and BamHI and introduced into the above constructed pUC19-SacB, thereby constructing an exchange vector (pPTA-sacB) for the disruption of pta and ackA (FIG. 4).
SEQ ID NO: 18: 5'-GAATTCGAGCTCGCCCGGGGATCGATCCTC
SEQ ID NO: 19: 5'-CCCGGGCCGACAGGCTTTGAAGCATGCAAATGTCAC
Example 4: Construction of M. succiniciproducens PALK strain A mutant strain was constructed by disrupting pta and ackA gene in the genome of M. succiniciproducens LK using pPTA-sacB, an exchange vector for the disruption of phosphotransacetylase gene (pta) and acetate kinase gene (ackA) constructed in Example 3 (FIG 4).
In other words, M. succiniciproducens LK constructed in Example 2 was plated on LB-glucose agar medium containing 10 g/L of glucose, and cultured at 37 C
for 36 hours. The colony formed was inoculated in 10 ml of LB-glucose liquid medium, and cultured for 12 hours. 1% of the culture broth, which had been sufficiently grown, was inoculated in 100 ml of LB-glucose liquid medium, and cultured in a shaking incubator at 200 rpm and 37 C.
Cell concentrate was collected from the resulting culture broth in the same manner as described in Example 2. The collected cell concentrate was mixed with the genetic exchange vector pPTA-sacB constructed in Examples 3, and then pPTA-sacB was introduced into the M. succiniciproducens LK by electroporation under conditions of 2.5 kV, 50 F and 200 ohms. 800 ml of LB-glucose liquid medium was added to the pPTA-sacB-introduced strain, and precultured in a thermostat at 37 C for one and a half hour. In order to induce a double crossover, the culture broth was plated on TSB-sucrose solid medium (Tryptic Soy Broth (Becton, Dickinson and Company) solid medium containing 100 g/L of sucrose) containing an antibiotic spectinomycin (final concentration of 50 g/ml) and cultured at 37 C for 48 hours or more. In order to screening a colony where only double crossover occurred, the colonies formed were streaked on TSB-sucrose medium containing 50 g/mi spectinomycin and TSB agar medium containing 50 g/ml ampicillin, respectively, and cultured at 37 C for 12 hours.
Then, the colonies, which were formed on the TSB-sucrose medium containing 50 g/mi spectinomycin but not formed on the TSB medium containing 50 g/ml ampicillin, were selected and streaked again on the TSB-sucrose medium containing 50 g/mi spectinomycin. The colonies formed herein were screened again using the spectinomycin-containing medium and the ampicillin-containing medium, and then the colonies which showed required results were selected ultimately. The isolated mutant genomic DNA as a template was amplified by PCR and the PCR product was electrophoresed to confirm the disruption of pta-ackA.
To confirm the disruption of pta-ackA, PCRs were performed twice in the following manner. First, the mutant genomic DNA as a template was subjected to PCR using primers set forth in SEQ ID NO: 20 and SEQ ID NO: 21. Then, the mutant genomic DNA as a template was subjected to PCR using primers set forth in SEQ ID NO: 22 and SEQ ID NO: 23.
SEQ ID NO: 20: 5'-CCTGCAGGCATGCAAGCTTGGGCTGCAGGTCGACTC
(SP 1) SEQ ID NO: 21: 5'-GCTGCCAAACAACCGAAAATACCGCAATAAACGGC
(PAU1) SEQ ID NO: 22:
5'-GCATGTAACTTTACTGGATATAGCTAGAAAAGGCATCGGGGAG (SP2) SEQ ID NO: 23:
5'-GCAACGCGAGGGTCAATACCGAAGGATTTCGCCG (PAD2) The products obtained in the two PCRs were subjected to gel electrophoresis to confirm the disruption of pta-ackA by their size (FIG. 6). The disruption of pta-ackA was confirmed by the fact the product resulted from the PCR using the primers of SEQ ID NO: 20 and SEQ ID NO: 21 (SP1 primer and PAU1 primer) has a size of 1.1 kb, and at the same time the product resulted from the PCR
using the primers of SEQ ID NO: 22 and SEQ ID NO: 23 (SP2 primer and PAD2 primer) has a size of 1.5 kb. The position of each primer is shown in FIG. 5.
The mutant strain constructed by the disruption of pta-ackA from the genome of M. succiniciproducens LK as the above-described method, i.e., a mutant strain resulted from the disruption of ldhA, pta and ackA from the genome of M.
succiniciproducens, was named "M. succiniciproducens PALK" and deposited under accession number "KCTC 10973BP" on July 26, 2006 in the Korean Collection for Type Cultures (KCTC; 52, Eoeun-dong, Yuseong-gu, Daejeon-si, Republic of Korea ), Korean Research Institute of Bioscience and Biotechnology, which is an international depositary authority.
Example 5: Production of homo-succinic acid using M. succiniciproducens PALK
M. succiniciproducens PALK (KCTC10973BP) constructed in Example 4 was plated on lOml of composition medium containing 5 g/L of glucose, and cultured in anaerobic conditions at 39 C for 8 hours, and then again moved to 250ml of composition medium containing 5 g/L of glucose and cultured at 39 C. At this time 50 g/mi spectinomycin was added to the medium as an antibiotic. 250m1 of the culture broth of M. succiniciproducens PALK was inoculated in the bioreactor containing 2.25L of composition medium (lg/L of NaCl, 2g/L of (NH4)2HP04, 0.02g/L of CaC12 = 2H20, 0.2g/L of MgC12 = 6H20, 8.709 g/L of K2HPO4, 0.5g/L of cystein, 0.5g/L of methionine, 0.5g/L of alanine, 0.5g/L of asparagines, 0.5g/L of aspartic acid, 0.5g/L of praline, 0.5g/L of serine, 0.005g/L
of nicotinic acid, 0.005g/L of Ca-pantothenate, 0.005g/L of pyridoxine = HCI, 0.005g/L of thiamine, 0.005g/L of ascorbic acid, and 0.005g/L of biotin), and the fermentation was performed under conditions of a first glucose concentration of 18.2g/L (100mM), a first glycerol concentration of 9.2g/L (100mM) at 39 C.
During the fermentation, the pH of the culture was adjusted to 6.5 by using ammonia water, and 50 g/mi spectinomycin was added to the medium as an antibiotic. In order to produce succinic acid at a high concentration, whenever glucose was completely exhausted, the glucose concentration of the culture broth was adjusted to about 18.2g/L (100mM) by adding concentrated glucose solution.
M. succiniciproducens MBEL55E (KCTC0769BP) and the succinic acid-producing mutant strain M. succiniciproducens LPK7 (KCTC 10626BP) were fermented to produce succinic acid in the same manner as described above.
The concentration of cells in the culture broth was measured with a spectrophotometer, and then calculated using the previously measured light absorption of spectrophotometer and the verification test for dried-cell weight.
During the fermentation, samples were collected from the bioreactor regularly.
The collected samples were centrifuged at 13,000 rpm for 10 minutes, and then the supernatants were used to analyze the concentrations of organic acids, glucose, and glycerol by using a High-Performance Liquid Chromatography.
As a result, when M. succiniciproducens PALK (KCTC10973BP) of the present invention was compared with M. succiniciproducens MBEL55E (KCTC0769BP) and M. succiniciproducens LPK7 (KCTC 10626BP), it showed higher succinic acid productivity while producing little or no other organic acids as byproducts than M. succiniciproducens MBEL55E (KCTC0769BP) and M.
succiniciproducens LPK7 (KCTC10626BP) as shown in FIG. 7 and Table 2.
Although 0.45g/L of acetic acid and 0.24g/L of pyruvic acid were detected, it is obvious to a person skilled in the art that these amount are the minimum amounts of organic acids produced for a strain to grow and can be ignored because they were produced in amounts of less than 1 wt% compared to produced succinic acid.
Table 2 Succinic acid-productivity ofM. succiniciproducens PALK (KCTC 1 0973BP) Strain MBEL55E LPK7 PALK
(KCTC0769BP) KCTC 10626BP) (KCTC 10973BP) Final concentration of 10.49 13.40 45.79 succinic acid (g/L) Glucose consumption 22.50 19.98 53.00 (g/L) Succinic acid yield (g 0.47 0.67 0.86 succinic acid / g glucose) Increasing rate of - 42.55 82.98 succinic acid compared to wild strain (MBEL55E) (%) Final concentration of 4.96 0.53 0.45 acetic acid (g/L) Final concentration of 3.47 0.27 0.00 lactic acid (g/L) Final concentration of 0.00 2.47 0.24 pyruvic acid (g/L) Cell specific growth rate 0.81 0.30 0.69 (1/h) INDUSTRIAL APPLICABILITY
As described and provided above in detail, the present invention provides the succinic acid-producing mutant microorganism having a high growth rate, which produces succinic acid at a high concentration while producing little or no other organic acids during the culture in anaerobic conditions, and the method for producing succinic acid using the same. The inventive mutant microorganism has the abilty of having a high growth rate and succinic acid productivity while producing little or no organic acids, as compared to the prior strains producing succinic acid. Thus, the inventive mutant microorganism is useful to produce succinic acid for industrial use.
While the present invention has been described in detail with reference to the specific features, it will be apparent to persons skilled in the art that this description is only for a preferred embodiment and does not limit the scope of the present invention. Thus, the substantial scope of the present invention will be defined by the appended claims and equivalents thereof.
SEQUENCE LISTING
The electronic file was attached.
(KCTC0769BP), thereby constructing a bacterial mutant M. succiniciproducens PALK (KCTC 10973BP) which shows a high growth rate and produces succinic acid at a high concentration while producing little or no other organic acids.
In the present invention, for the disruption of each gene, a method of substituting the genes by homologous recombination to inactivate was used, but any method can be used without limitations as long as it is genetic manipulation method where the corresponding gene can be modified or eliminated, such that an enzyme encoded by the corredponding gene is not generated.
In the present invention, the rumen bacteria are selected from the group consisting of Mannheimia sp., Actinobacillus sp. and Anaerobiospirillum sp.
In the present invention, the mutant microorganism is preferably a homogeneous fermentation strain producing only succinic acid while forming little or no other organic acids as byproducts, the amounts of other organic acids produced are preferably less than lwt% based on the amount of succinic acid produced, and the other organic acids are preferably any one or more organic acids selected from the group consisting of lactic acid, acetic acid, formic acid, and pyruvic acid.
In another aspect, the present invention relates to a rumen bacterial mutant M.
succiniciproducens PALK (KCTC10973BP), lacking a lactate dehydrogenase gene (ldhA), a phosphotransacetylase gene (pta), and an acetate kinase gene (ackA) in M. succiniciproducens while a pyruvate formate-lyase gene (pfl) is maintained in M. succiniciproducens, which has the property of producing succinic acid at a high concentration while producing little or no other organic acids in anaerobic conditions.
The bacterial mutant M. succiniciproducens LPK7 (KCTC10626BP), which was constructed by disrupting a gene encoding lactate dehydrogenase (ldhA), a gene encoding pyruvate formate-lyase (pfl), a gene encoding phosphotransacetylase (pta), and a gene encoding acetate kinase (ackA) in the genome of Mannheimia sp., was used in order to compare the succinic acid productivity and growth rate of M. succiniciproducens PALK (KCTC10973BP) according to the present invention with those of traditional bacterial mutants. Herein, the bacterial mutant M. succiniciproducens LPK7 (KCTC 10626BP) has an additional disruption of a gene encoding pyruvate formate-lyase (pfl) in the mutant strain M.
succiniciproducens PALK (KCTC10973BP) according to the present invention (W02005/052135; Lee et al., Appl. Environ. Microbiol. 72:1939, 2006).
M. succiniciproducens PALK (KCTC10973BP) according to the present invention has a high succinic acid productivity and produces little or no byproducts such as lactic acid, acetic acid, formic acid, and pyruvic acid, thus showing excellent properties compared to wild-type M. succiniciproducens MBEL55E
(KCTC0769BP) for succinic acid production and previously constructed bacterial mutant M. succiniciproducens LPK7 (KCTC10626BP), and can produce succinic acid at a high yields due to a high growth rate thereof, high succinic acid productivity and homo-succinic acid production by preventing pyruvic acid accumulation, compared to previously constructed bacterial mutant M.
succiniciproducens LPK7 (KCTC 10626BP).
In still another aspect, the present invention relates to a method for constructing a mutant microorganism, the method comprising the steps of: (a) obtaining a rumen bacterial mutant lacking a gene encoding lactate dehydrogenase (ldhA) by disrupting a gene encoding lactate dehydrogenase (ldhA) in genome of succinic acid producing rumen bacteria using homologous recombination; and (b) obtaining a rumen bacterial mutant lacking a gene encoding lactate dehydrogenase (ldhA), a gene encoding phosphotransacetylase (pta), and a gene encoding acetate kinase (ackA) by disrupting a gene encoding phosphotransacetylase (pta) and a gene encoding acetate kinase (ackA) in genome of the rumen bacterial mutant lacking a gene encoding lactate dehydrogenase (ldhA) by homologous recombination,.
In the present invention, the homologous recombination of the step (a) is preferably performed using a genetic exchange vector containing a disrupted ldhA, and the homologous recombination of the step (b) is preferably performed using a genetic exchange vector containing a disrupted pta-ackA.
In the present invention, the genetic exchange vector containing a disrupted ldhA
is preferably pMLKO-sacB, and the genetic exchange vector containing a disrupted pta-ackA is preferably pMPKO-sacB.
The present invention also provides a method for producing succinic acid, the method comprising the steps of: culturing the above-mentioned mutant microorganism in anaerobic conditions; and recovering succinic acid from the culture broth.
In the present invention, for the culture, glucose or glycerol is preferably used as a carbon source, and the amounts of other organic acids produced as byproducts are preferably less than 1 wt% based on the amount of succinic acid produced.
In yet another aspect, the present invention relates to a method for preparing succinic acid, the method comprising the steps of: culturing the rumen bacterial mutant in anaerobic conditions; and recovering succinic acid from the culture broth.
The culture of the succinic acid producing mutant microorganism according to the present invention and recovery process of succinic acid can be performed by the culture methods known in the conventional fermentation process and methods for separating and purifying succinic acid.
In the present invention, for the culture, glucose or glycerol is preferably used as a carbon source, and the amounts of other organic acids produced as byproducts are preferably less than 1 wt% based on the amount of succinic acid produced.
Examples The present invention will hereinafter be described in further details by examples.
It will however be obvious to a person skilled in the art that these examples are given for illustrative purpose only, and the present invention is not limited to or by the examples.
Particularly, the following examples illustrate only Mannheimia sp. which is a succinic acid-producing microorganism as a host cell in order to delete the genes according to the present invention. However, it is obvious to a person skilled in the art that a mutant microorganism producing homo-succinic acid can be obtained even when other kinds of succinic acid producing microorganisms are used.
Example 1: Construction of ldhA disruption vector (pMLKO-sacB) In order to disrupt a lactate dehydrogenase gene (ldhA) in the genome of a succinic acid-producing microorganism by homologous recombination, a gene exchange vector was constructed in the following manner. First, the genomic DNA of M. succiniciproducens MBEL55E (KCTC 0769BP), as a template, was subjected to PCR using primers set forth in SEQ ID NO: 1 and SEQ ID NO: 2 below, and then, the obtained PCR fragment containing ldhA-homologous region 1 (L1) was cut with SacI and Pstl and introduced into pUC 18 vector (New England Biolabs, Inc., USA), thereby constructing pUC18-L1.
SEQ ID NO: 1: 5'-CAGTGAAGGAGCTCCGTAACGCATCCGCCG
SEQ ID NO: 2: 5'-CTTTATCGAATCTGCAGGCGGTTTCCAAAA
In addition, the genomic DNA of M. succiniciproducens MBEL55E (KCTC
0769BP), as a template, was subjected to PCR using primers set forth in SEQ ID
NO: 3 and SEQ ID NO: 4 below, and then, the obtained PCR fragment containing ldhA-homologous region 2 (L2) was cut with Pstl and HindIII and introduced into the pUC 18-L 1, thereby constructing pUC 18-L 1-L2.
SEQ ID NO: 3: 5'-GTACTGTAAACTGCAGCTTTCATAGTTAGC
SEQ ID NO: 4: 5'-GCCGAAAGTCAAGCTTGCCGTCGTTTAGTG
In order to insert kanamycin-resistant gene as a selection marker in the pUC
L1-L2, pUC4K vector (Pharmacia, Germany) was cut with Pstl, and the resulting kanamycin-resistant gene was fused with pUC18-L1-L2 cut with PstI, thereby constructing pUC 18-L 1-KmR-L2. A linker set forth in SEQ ID NO: 5 was inserted into the pUC 18-L 1-KmR-L2 cut with SacI, thereby making a new Xbal cutting site.
SEQ ID NO: 5: 5'-TCTAGAAGCT
In order to insert sacB gene in the pUC18-L1- KmR-L2 into which the Xbal cutting site has been inserted, PCR on pKmobsacB (Schafer et al., Gene, 145:69, 1994) as a template was performed using primers set forth in SEQ ID NO: 6 and 7.
Then the resulting PCR fragment containing sacB gene was cut with Xbal, and inserted into the new XbaI restriction enzyme site of pUC18-L1-KmR-L2 into which the above Xbal cutting site has been inserted, thereby constructing pMLKO-sacB, an exchange vector for disrupting ldhA gene (FIG. 2).
SEQ ID NO: 6: 5'-GCTCTAGACCTTCTATCGCCTTCTTGACG
SEQ ID NO: 7: 5'-GCTCTAGAGGCTACAAAATCACGGGCGTC
Example 2: Construction of M. succiniciproducens LK strain A mutant strain was constructed by disrupting ldhA gene in the genome of M.
succiniciproducens MBEL55E (KCTC0769BP) using pMLKO-sacB constructed in Example 1 as a genetic exchange vector for disrupting ldhA gene (FIG. 3).
In other words, M. succiniciproducens MBEL55E (KCTC0769BP) was plated on LB-glucose agar medium containing 10 g/L of glucose, and cultured at 37 C for 36 hours. The colony formed was inoculated in 10 ml of LB-glucose liquid medium, and cultured for 12 hours. 1% of the culture broth, which had been sufficiently grown, was inoculated in 100 ml of LB-glucose liquid medium, and cultured in a shaking incubator at 200 rpm and 37 C.
When the culture broth reached an OD600 of about 0.3-0.4 after 4-5hours, it was centrifuged at 4 C and 4,500 rpm for 20 minutes to collect cells. Then, the cells were resuspended in 200 ml of 10% glycerol solution at 4 C. The suspension was centrifuged at 4 C and 5,500 rpm for 20 minutes, and the cells were collected.
After resuspending and collecting in one-half of the above glycerol solution twice in the same manner as the above-described processes, the cells were suspended in glycerol at a volume ratio of 1:1, to obtain cell concentrate.
The cell concentrate thus obtained was mixed with the genetic exchange vector pMLKO-sacB constructed in Example 1, and then pMLKO-sacB was introduced into the cultured M. succiniciproducens MBEL55E (KCTC0769BP) by electroporation under conditions of 1.8 kV, 25 F and 200 ohms. 1 ml of LB-glucose liquid medium was added to the pMLKO-sacB-introduced strain, and precultured in a shaking incubator at 37 C and 200rpm for one hour. The culture broth was plated on LB-glucose solid medium containing an antibiotic kanamycin (final concentration of 25 g/ml) and cultured at 37 C for 48 hours or more.
In order to select a colony where only double crossover occurred, the colonies formed were streaked on LB-sucrose solid medium containing kanamycin (25 g/ml) and 100g/L sucrose. After 24 hours, the formed colonies were streaked again on the same medium.
The colonise (mutant) formed on the medium were cultured in LB-glucose liquid medium containing an antibiotic, and genomic DNA was isolated from the cultured strain by the method described in Rochelle et al. (Rochelle et al., FEMS
Microbiol. Lett., 100:59, 1992). PCR was performed using the isolated mutant genomic DNA as a template, and the PCR product was electrophoresed to confirm the disruption of ldhA gene in the genomic DNA.
In order to confirm the disruption of the ldhA gene, PCRs were performed twice in the following manners. First, the mutant genomic DNA as a template was subjected to PCR using primers set forth in SEQ ID NO: 8 and SEQ ID NO: 9.
SEQ ID NO: 8: 5'-GACGTTTCCCGTTGAATATGGC (KM1) SEQ ID NO: 9: 5'-CATTGAGGCGTATTATCAGGAAAC (LU1) Then, the mutant genomic DNA as a template was subjected to PCR using primers set forth in SEQ ID NO: 10 and SEQ ID NO: 11.
SEQ ID NO: 10: 5'-GCAGTTTCATTTGATGCTCGATG (KM2) SEQ ID NO: 11: 5'-CCTCTTACGATGACGCATCTTTCC (LD2) The PCR fragments obtained in the two PCRs were subjected to gel electrophoresis to confirm the disruption of ldhA by their size. The PCR
fragments of the genomic DNA having disrupted ldhA were confirmed by the fact that the product resulted from the PCR using the primers of SEQ ID NO: 8 (KM
1) and SEQ ID NO: 9(LU1) has a size of 1.5 kb, and at the same time the product resulted from the PCR using the primers of SEQ ID NO: 10 (KM2) and SEQ ID
NO: 11 (LU2) has a size of 1.7 kb. The position of each primer is shown in FIG. 3.
The mutant strain M. succiniciproducens LK was constructed by disrupting ldhA
gene in the genome of M. succiniciproducens MBEL55E according to the above method.
Example 3: Construction of gene exchange vector (pPTA-sacB) for the disruption of pta and ackA
In order to disrupt pta and ackA in the genome of M. succinicproducens LK
strain by homologous recombination, a genetic exchange vector was constructed in the following manner. A vector pKmobsacB containing a sacB gene, as a template, was subjected to PCR using primers set forth in SEQ ID NO: 12 and SEQ ID NO:
13. The resulting sacB product was cut with Pstl and BamHI and inserted into pUC19 (Stratagene Cloning Systems. USA), thereby constructing pUC19-sacB
(FIG 4).
SEQ ID NO: 12: 5'-AGCGGATCCCCTTCTATCGCCTTCTTGACG
SEQ ID NO: 13: 5'-GTCCTGCAGGGCTACAAAATCACGGGCGTC
Meanwhile, the genomic DNA of M. succiniciproducens LK as a template was subjected to PCR using primers set forth in SEQ ID NO: 14 and SEQ ID NO: 15, and the resulting PCR fragment containing pta-ackA homologous region 1 was cut with Xbal and BamH1. In addition, the genomic DNA of M.
succiniciproducens LK as a template was subjected to PCR using primers set forth in SEQ ID NO: 16 and SEQ ID NO: 17, and the resulting PCR fragment containing pta-ackA homologous region 2 was cut with Xbal and SacI. Then, these fragments were inserted into BamHI and SacI site of pUC19, thereby constructing pUC 19-PTA 12.
SEQ ID NO: 14: 5'-GCTCTAGATATCCGCAGTATCACTTTCTGCGC
SEQ ID NO: 15: 5'-TCCGCAGTCGGATCCGGGTTAACCGCACAG
SEQ ID NO: 16: 5'-GGGGAGCTCGCTAACTTAGCTTCTAAAGGCCA
TGTTTCC
SEQ ID NO: 17: 5'-GCTCTAGATATCCGGGTCAATATCGCCGCAAC
In order to insert a spectinomycin-resistant gene (GenBank X02588; SpR) as a selective marker in pUC19-PTA12, plasmid pIC156 (Steinmetz et al., Gene, 142:79, 1994) containing a spectinomycin-resistant gene (GenBank X02588), as a template, was subjected to PCR using primers set forth in SEQ ID NO: 18 and SEQ ID NO: 19, and the resulting PCR fragment containing SpR gene was cut with EcoRV and introduced into the pUC 19-PTA12, thereby constructing pUC 19-PTAl S2 having the spectinomycin-resistant gene. The constructed pUC 19-PTA1S2 was cut with SacI and BamHI and introduced into the above constructed pUC19-SacB, thereby constructing an exchange vector (pPTA-sacB) for the disruption of pta and ackA (FIG. 4).
SEQ ID NO: 18: 5'-GAATTCGAGCTCGCCCGGGGATCGATCCTC
SEQ ID NO: 19: 5'-CCCGGGCCGACAGGCTTTGAAGCATGCAAATGTCAC
Example 4: Construction of M. succiniciproducens PALK strain A mutant strain was constructed by disrupting pta and ackA gene in the genome of M. succiniciproducens LK using pPTA-sacB, an exchange vector for the disruption of phosphotransacetylase gene (pta) and acetate kinase gene (ackA) constructed in Example 3 (FIG 4).
In other words, M. succiniciproducens LK constructed in Example 2 was plated on LB-glucose agar medium containing 10 g/L of glucose, and cultured at 37 C
for 36 hours. The colony formed was inoculated in 10 ml of LB-glucose liquid medium, and cultured for 12 hours. 1% of the culture broth, which had been sufficiently grown, was inoculated in 100 ml of LB-glucose liquid medium, and cultured in a shaking incubator at 200 rpm and 37 C.
Cell concentrate was collected from the resulting culture broth in the same manner as described in Example 2. The collected cell concentrate was mixed with the genetic exchange vector pPTA-sacB constructed in Examples 3, and then pPTA-sacB was introduced into the M. succiniciproducens LK by electroporation under conditions of 2.5 kV, 50 F and 200 ohms. 800 ml of LB-glucose liquid medium was added to the pPTA-sacB-introduced strain, and precultured in a thermostat at 37 C for one and a half hour. In order to induce a double crossover, the culture broth was plated on TSB-sucrose solid medium (Tryptic Soy Broth (Becton, Dickinson and Company) solid medium containing 100 g/L of sucrose) containing an antibiotic spectinomycin (final concentration of 50 g/ml) and cultured at 37 C for 48 hours or more. In order to screening a colony where only double crossover occurred, the colonies formed were streaked on TSB-sucrose medium containing 50 g/mi spectinomycin and TSB agar medium containing 50 g/ml ampicillin, respectively, and cultured at 37 C for 12 hours.
Then, the colonies, which were formed on the TSB-sucrose medium containing 50 g/mi spectinomycin but not formed on the TSB medium containing 50 g/ml ampicillin, were selected and streaked again on the TSB-sucrose medium containing 50 g/mi spectinomycin. The colonies formed herein were screened again using the spectinomycin-containing medium and the ampicillin-containing medium, and then the colonies which showed required results were selected ultimately. The isolated mutant genomic DNA as a template was amplified by PCR and the PCR product was electrophoresed to confirm the disruption of pta-ackA.
To confirm the disruption of pta-ackA, PCRs were performed twice in the following manner. First, the mutant genomic DNA as a template was subjected to PCR using primers set forth in SEQ ID NO: 20 and SEQ ID NO: 21. Then, the mutant genomic DNA as a template was subjected to PCR using primers set forth in SEQ ID NO: 22 and SEQ ID NO: 23.
SEQ ID NO: 20: 5'-CCTGCAGGCATGCAAGCTTGGGCTGCAGGTCGACTC
(SP 1) SEQ ID NO: 21: 5'-GCTGCCAAACAACCGAAAATACCGCAATAAACGGC
(PAU1) SEQ ID NO: 22:
5'-GCATGTAACTTTACTGGATATAGCTAGAAAAGGCATCGGGGAG (SP2) SEQ ID NO: 23:
5'-GCAACGCGAGGGTCAATACCGAAGGATTTCGCCG (PAD2) The products obtained in the two PCRs were subjected to gel electrophoresis to confirm the disruption of pta-ackA by their size (FIG. 6). The disruption of pta-ackA was confirmed by the fact the product resulted from the PCR using the primers of SEQ ID NO: 20 and SEQ ID NO: 21 (SP1 primer and PAU1 primer) has a size of 1.1 kb, and at the same time the product resulted from the PCR
using the primers of SEQ ID NO: 22 and SEQ ID NO: 23 (SP2 primer and PAD2 primer) has a size of 1.5 kb. The position of each primer is shown in FIG. 5.
The mutant strain constructed by the disruption of pta-ackA from the genome of M. succiniciproducens LK as the above-described method, i.e., a mutant strain resulted from the disruption of ldhA, pta and ackA from the genome of M.
succiniciproducens, was named "M. succiniciproducens PALK" and deposited under accession number "KCTC 10973BP" on July 26, 2006 in the Korean Collection for Type Cultures (KCTC; 52, Eoeun-dong, Yuseong-gu, Daejeon-si, Republic of Korea ), Korean Research Institute of Bioscience and Biotechnology, which is an international depositary authority.
Example 5: Production of homo-succinic acid using M. succiniciproducens PALK
M. succiniciproducens PALK (KCTC10973BP) constructed in Example 4 was plated on lOml of composition medium containing 5 g/L of glucose, and cultured in anaerobic conditions at 39 C for 8 hours, and then again moved to 250ml of composition medium containing 5 g/L of glucose and cultured at 39 C. At this time 50 g/mi spectinomycin was added to the medium as an antibiotic. 250m1 of the culture broth of M. succiniciproducens PALK was inoculated in the bioreactor containing 2.25L of composition medium (lg/L of NaCl, 2g/L of (NH4)2HP04, 0.02g/L of CaC12 = 2H20, 0.2g/L of MgC12 = 6H20, 8.709 g/L of K2HPO4, 0.5g/L of cystein, 0.5g/L of methionine, 0.5g/L of alanine, 0.5g/L of asparagines, 0.5g/L of aspartic acid, 0.5g/L of praline, 0.5g/L of serine, 0.005g/L
of nicotinic acid, 0.005g/L of Ca-pantothenate, 0.005g/L of pyridoxine = HCI, 0.005g/L of thiamine, 0.005g/L of ascorbic acid, and 0.005g/L of biotin), and the fermentation was performed under conditions of a first glucose concentration of 18.2g/L (100mM), a first glycerol concentration of 9.2g/L (100mM) at 39 C.
During the fermentation, the pH of the culture was adjusted to 6.5 by using ammonia water, and 50 g/mi spectinomycin was added to the medium as an antibiotic. In order to produce succinic acid at a high concentration, whenever glucose was completely exhausted, the glucose concentration of the culture broth was adjusted to about 18.2g/L (100mM) by adding concentrated glucose solution.
M. succiniciproducens MBEL55E (KCTC0769BP) and the succinic acid-producing mutant strain M. succiniciproducens LPK7 (KCTC 10626BP) were fermented to produce succinic acid in the same manner as described above.
The concentration of cells in the culture broth was measured with a spectrophotometer, and then calculated using the previously measured light absorption of spectrophotometer and the verification test for dried-cell weight.
During the fermentation, samples were collected from the bioreactor regularly.
The collected samples were centrifuged at 13,000 rpm for 10 minutes, and then the supernatants were used to analyze the concentrations of organic acids, glucose, and glycerol by using a High-Performance Liquid Chromatography.
As a result, when M. succiniciproducens PALK (KCTC10973BP) of the present invention was compared with M. succiniciproducens MBEL55E (KCTC0769BP) and M. succiniciproducens LPK7 (KCTC 10626BP), it showed higher succinic acid productivity while producing little or no other organic acids as byproducts than M. succiniciproducens MBEL55E (KCTC0769BP) and M.
succiniciproducens LPK7 (KCTC10626BP) as shown in FIG. 7 and Table 2.
Although 0.45g/L of acetic acid and 0.24g/L of pyruvic acid were detected, it is obvious to a person skilled in the art that these amount are the minimum amounts of organic acids produced for a strain to grow and can be ignored because they were produced in amounts of less than 1 wt% compared to produced succinic acid.
Table 2 Succinic acid-productivity ofM. succiniciproducens PALK (KCTC 1 0973BP) Strain MBEL55E LPK7 PALK
(KCTC0769BP) KCTC 10626BP) (KCTC 10973BP) Final concentration of 10.49 13.40 45.79 succinic acid (g/L) Glucose consumption 22.50 19.98 53.00 (g/L) Succinic acid yield (g 0.47 0.67 0.86 succinic acid / g glucose) Increasing rate of - 42.55 82.98 succinic acid compared to wild strain (MBEL55E) (%) Final concentration of 4.96 0.53 0.45 acetic acid (g/L) Final concentration of 3.47 0.27 0.00 lactic acid (g/L) Final concentration of 0.00 2.47 0.24 pyruvic acid (g/L) Cell specific growth rate 0.81 0.30 0.69 (1/h) INDUSTRIAL APPLICABILITY
As described and provided above in detail, the present invention provides the succinic acid-producing mutant microorganism having a high growth rate, which produces succinic acid at a high concentration while producing little or no other organic acids during the culture in anaerobic conditions, and the method for producing succinic acid using the same. The inventive mutant microorganism has the abilty of having a high growth rate and succinic acid productivity while producing little or no organic acids, as compared to the prior strains producing succinic acid. Thus, the inventive mutant microorganism is useful to produce succinic acid for industrial use.
While the present invention has been described in detail with reference to the specific features, it will be apparent to persons skilled in the art that this description is only for a preferred embodiment and does not limit the scope of the present invention. Thus, the substantial scope of the present invention will be defined by the appended claims and equivalents thereof.
SEQUENCE LISTING
The electronic file was attached.
Claims (16)
1. A bacterial mutant lacking a lactate dehydrogenase gene (ldhA), a phosphotransacetylase gene (pta), and an acetate kinase gene (ackA) while comprising a pyruvate formate-lyase gene (pfl), which has the property of producing succinic acid at a high concentration while other organic acids are produced as byproducts in little or no amount in anaerobic conditions, wherein the bacterial mutant is selected from the group consisting of genus Mannheimia, genus Actinobacillus and genus Anaerobiospirillum.
2. The bacterial mutant according to claim 1, wherein the bacteria are homogeneous fermentation strains.
3. The bacterial mutant according to claim 1, wherein if other organic acids are produced as byproducts, the respective amount of each of said other organic acids produced as byproducts is less than 1 wt% based on the amount of succinic acid produced.
4. The bacterial mutant according to claim 1, wherein the other organic acids are any one or more organic acids selected from the group consisting of lactic acid, acetic acid, formic acid, and pyruvic acid.
5. A bacterial mutant Mannheimia succiniciproducens PALK (KCTC10973BP), lacking a lactate dehydrogenase gene (IdhA), a phosphotransacetylase gene (pta), and an acetate kinase gene (ack4) in Mannheimia succiniciproducens while comprising a pyruvate formate-lyase gene (pfl), which has the property of producing succinic acid at a high concentration while producing little or no other organic acids in anaerobic conditions.
6. A method for producing the bacterial mutant of claim 1, the method comprising the steps of:
(a) obtaining a bacterial mutant lacking a gene encoding lactate dehydrogenase (ldhA) by disrupting a gene encoding lactate dehydrogenase (ldhA) in the genome of a bacteria which is selected from the group consisting of genus Mannheimia, genus Actinobacillus and genus Anaerobiospirillum, using homologous recombination; and (b) obtaining a bacterial mutant lacking a gene encoding lactate dehydrogenase (ldhA), a gene encoding phosphotransacetylase (pta), and a gene encoding acetate kinase (ackA) by disrupting a gene encoding phosphotransacetylase (pta), and a gene encoding acetate kinase (ackA) in the genome of the bacterial mutant lacking a gene encoding lactate dehydrogenase (ldhA) by homologous recombination.
(a) obtaining a bacterial mutant lacking a gene encoding lactate dehydrogenase (ldhA) by disrupting a gene encoding lactate dehydrogenase (ldhA) in the genome of a bacteria which is selected from the group consisting of genus Mannheimia, genus Actinobacillus and genus Anaerobiospirillum, using homologous recombination; and (b) obtaining a bacterial mutant lacking a gene encoding lactate dehydrogenase (ldhA), a gene encoding phosphotransacetylase (pta), and a gene encoding acetate kinase (ackA) by disrupting a gene encoding phosphotransacetylase (pta), and a gene encoding acetate kinase (ackA) in the genome of the bacterial mutant lacking a gene encoding lactate dehydrogenase (ldhA) by homologous recombination.
7. The method for producing the bacterial mutant according to claim 6, wherein the homologous recombination of the step (a) is performed using a genetic exchange vector containing a disrupted ldhA.
8. The method for producing the bacterial mutant according to claim 6, wherein the homologous recombination of the step (b) is performed using a genetic exchange vector containing a disrupted pta-ackA.
9. The method for producing the bacterial mutant according to claim 7, wherein the genetic exchange vector containing a disrupted ldhA is pMLKO-sacB.
10. The method for producing the bacterial mutant according to claim 8, wherein the genetic exchange vector containing a disrupted pta-ackA is pMPKO-sacB.
11. A method for producing succinic acid, the method comprising the steps of:
culturing the bacterial mutant of any one claim among claims 1-4 in anaerobic conditions; and recovering succinic acid from the culture broth.
culturing the bacterial mutant of any one claim among claims 1-4 in anaerobic conditions; and recovering succinic acid from the culture broth.
12. The method for producing succinic acid according to claim 11, wherein glucose or glycerol is used as a carbon source for the culture.
13. The method for preparing succinic acid according to claim 11, wherein amounts of said other organic acids are produced as byproducts, and the respective amount of each of said other organic acids produced as byproducts is less than 1 wt% based on the amount of succinic acid produced.
14. A method for preparing succinic acid, the method comprising the steps of:
culturing the bacterial mutant Mannheimia succiniciproducens PALK
(KCTC10973BP) in anaerobic conditions; and recovering succinic acid from the culture broth.
culturing the bacterial mutant Mannheimia succiniciproducens PALK
(KCTC10973BP) in anaerobic conditions; and recovering succinic acid from the culture broth.
15. The method for preparing succinic acid according to claim 14, wherein glucose or glycerol is used as a carbon source for the culture.
16. The method for preparing succinic acid according to claim 14, wherein other organic acids are produced as byproducts, and the respective amount of each of said other organic acids produced as byproducts is less than 1 wt% based on the amount of succinic acid produced.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020060071666A KR100780324B1 (en) | 2006-07-28 | 2006-07-28 | Novel engineered microorganism producing homo-succinic acid and method for preparing succinic acid using the same |
| KR10-2006-0071666 | 2006-07-28 | ||
| PCT/KR2007/003574 WO2008013405A1 (en) | 2006-07-28 | 2007-07-25 | Novel engineered microorganism producing homo-succinic acid and method for preparing succinic acid using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2659246A1 CA2659246A1 (en) | 2008-01-31 |
| CA2659246C true CA2659246C (en) | 2014-11-25 |
Family
ID=38981687
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2659246A Active CA2659246C (en) | 2006-07-28 | 2007-07-25 | Novel engineered microorganism producing homo-succinic acid and method for preparing succinic acid using the same |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US9217138B2 (en) |
| EP (1) | EP2054502B2 (en) |
| JP (1) | JP5421103B2 (en) |
| KR (1) | KR100780324B1 (en) |
| CN (1) | CN101636488B (en) |
| AU (1) | AU2007277593B2 (en) |
| BR (1) | BRPI0713839B1 (en) |
| CA (1) | CA2659246C (en) |
| DK (1) | DK2054502T4 (en) |
| ES (1) | ES2464159T5 (en) |
| MX (1) | MX2009001004A (en) |
| MY (1) | MY162581A (en) |
| NZ (1) | NZ575237A (en) |
| PT (1) | PT2054502E (en) |
| RU (1) | RU2415942C2 (en) |
| WO (1) | WO2008013405A1 (en) |
| ZA (1) | ZA200901254B (en) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100780324B1 (en) * | 2006-07-28 | 2007-11-29 | 한국과학기술원 | Novel engineered microorganism producing homo-succinic acid and method for preparing succinic acid using the same |
| KR101103839B1 (en) | 2007-07-12 | 2012-01-06 | 한국과학기술원 | Homo-Succinic Acid Producing Microorganism Variant and Process for Preparing Succinic Acid Using the Same |
| WO2009014289A1 (en) * | 2007-07-25 | 2009-01-29 | Korea Advanced Institute Of Science And Technology | Method for preparing succinic acid using sucrose as a carbon source |
| CN103589662A (en) | 2007-08-17 | 2014-02-19 | 巴斯夫欧洲公司 | Carboxylic Acid Producing Member of the Pasteurellaceae |
| EP2204443B1 (en) | 2008-12-23 | 2015-11-25 | Basf Se | Bacterial cells exhibiting formate dehydrogenase activity for the manufacture of suc-cinic acid |
| EP2202294B1 (en) | 2008-12-23 | 2015-10-21 | Basf Se | Bacterial cells having a glyoxylate shunt for the manufacture of succinic acid |
| WO2010092155A1 (en) | 2009-02-16 | 2010-08-19 | Basf Se | Novel microbial succinic acid producers and purification of succinic acid |
| EP2233562A1 (en) | 2009-03-24 | 2010-09-29 | Metabolic Explorer | Method for producing high amount of glycolic acid by fermentation |
| KR101221557B1 (en) * | 2010-08-30 | 2013-01-14 | 한국과학기술원 | Novel Engineered Microorganism Producing Succinic Acid with High Yield by Utilizing Both Sucrose and Glycerol at the Same Time and Method for Preparing Succinic Acid Using the Same |
| KR20140061303A (en) * | 2011-02-11 | 2014-05-21 | 리전츠 오브 더 유니버스티 오브 미네소타 | Cells and methods for producing isobutyric acid |
| US9657316B2 (en) | 2012-08-27 | 2017-05-23 | Genomatica, Inc. | Microorganisms and methods for enhancing the availability of reducing equivalents in the presence of methanol, and for producing 1,4-butanediol related thereto |
| US11535874B2 (en) | 2012-10-22 | 2022-12-27 | Genomatica, Inc. | Microorganisms and methods for enhancing the availability of reducing equivalents in the presence of methanol, and for producing succinate related thereto |
| EP3862421A1 (en) | 2012-12-17 | 2021-08-11 | Genomatica, Inc. | Microorganisms and methods for enhancing the availability of reducing equivalents in the presence of methanol, and for producing adipate, 6-aminocaproate, hexamethylenediamine or caprolactam related thereto |
| CN104531782A (en) * | 2014-12-31 | 2015-04-22 | 南京工业大学 | Method for producing pyruvic acid by micro-aerobic fermentation of actinobacillus |
| CN104946576B (en) * | 2015-04-27 | 2018-03-23 | 中国科学院过程工程研究所 | Recombinant organism and its construction method and the application in pyruvic acid is produced |
| WO2016191142A2 (en) * | 2015-05-27 | 2016-12-01 | Verily Life Sciences Llc | Nanophotonic hyperspectral/lightfield superpixel imager |
| US11541105B2 (en) | 2018-06-01 | 2023-01-03 | The Research Foundation For The State University Of New York | Compositions and methods for disrupting biofilm formation and maintenance |
| KR102129379B1 (en) * | 2018-10-10 | 2020-07-02 | 한국과학기술원 | A recombinant microorganism into which a high activity malate dehydrogenase for producing succinic acid and a method for producing succinic acid using the same |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5168055A (en) | 1986-06-11 | 1992-12-01 | Rathin Datta | Fermentation and purification process for succinic acid |
| ES2036188T3 (en) | 1986-06-11 | 1993-05-16 | Michigan Biotechnology Institute | A PROCEDURE FOR THE PRODUCTION OF SUCCINIC ACID BY ANAEROBIC FERMENTATION. |
| US5143834A (en) | 1986-06-11 | 1992-09-01 | Glassner David A | Process for the production and purification of succinic acid |
| US5439873A (en) | 1994-02-23 | 1995-08-08 | Plant Growth Development Corporation | Method for stimulating plant growth using GABA |
| US5521075A (en) | 1994-12-19 | 1996-05-28 | Michigan Biotechnology Institute | Method for making succinic acid, anaerobiospirillum succiniciproducens variants for use in process and methods for obtaining variants |
| US5504004A (en) | 1994-12-20 | 1996-04-02 | Michigan Biotechnology Institute | Process for making succinic acid, microorganisms for use in the process and methods of obtaining the microorganisms |
| US5573931A (en) | 1995-08-28 | 1996-11-12 | Michigan Biotechnology Institute | Method for making succinic acid, bacterial variants for use in the process, and methods for obtaining variants |
| US5770435A (en) | 1995-11-02 | 1998-06-23 | University Of Chicago | Mutant E. coli strain with increased succinic acid production |
| KR19990013007A (en) | 1997-07-31 | 1999-02-25 | 박원훈 | Transformed Escherichia Coli S373 (BTCC 8818 P) and Production Method of Succinic Acid Using the Same |
| US7351578B2 (en) | 1999-12-10 | 2008-04-01 | Invitrogen Corp. | Use of multiple recombination sites with unique specificity in recombinational cloning |
| JP4074365B2 (en) | 1998-01-28 | 2008-04-09 | 三菱化学株式会社 | Lactate dehydrogenase gene and gene-disrupted strain |
| US6159738A (en) | 1998-04-28 | 2000-12-12 | University Of Chicago | Method for construction of bacterial strains with increased succinic acid production |
| AU785483B2 (en) | 1999-12-10 | 2007-09-20 | Invitrogen Corporation | Use of multiple recombination sites with unique specificity in recombinational cloning |
| KR100372218B1 (en) * | 2000-06-29 | 2003-02-14 | 바이오인포메틱스 주식회사 | Organic Acid Producing Microorganism and Process for Preparing Organic Acids Employing the Same |
| US6743610B2 (en) | 2001-03-30 | 2004-06-01 | The University Of Chicago | Method to produce succinic acid from raw hydrolysates |
| NZ547305A (en) | 2003-11-27 | 2009-05-31 | Korea Advanced Inst Sci & Tech | Rumen bacteria variants and process for preparing succinic acid employing the same |
| KR100630819B1 (en) * | 2004-04-23 | 2006-10-02 | 한국과학기술원 | Novel Rumen Bacteria Variants and Method for Preparing Succinic Acid Using the Same |
| KR20050051149A (en) * | 2003-11-27 | 2005-06-01 | 한국과학기술원 | Variant of lumen bacteria and process for preparing succinic acid employing the same |
| EP1781797B1 (en) | 2004-08-27 | 2016-10-19 | Rice University | Mutant e. coli strain with increased succinic acid production |
| JP2008513023A (en) * | 2004-09-17 | 2008-05-01 | ライス ユニバーシティー | Highly succinic acid producing bacteria |
| US7569380B2 (en) | 2004-12-22 | 2009-08-04 | Rice University | Simultaneous anaerobic production of isoamyl acetate and succinic acid |
| KR100676160B1 (en) | 2005-08-19 | 2007-02-01 | 한국과학기술원 | Microorganisms transformed with gene encoding malic enzyme and method for preparing succinic acid using the same |
| KR100679638B1 (en) | 2005-08-19 | 2007-02-06 | 한국과학기술원 | Microorganisms transformed with gene encoding formate ddehydrogenase d or e and method for preparing succinic acid using the same |
| KR100727054B1 (en) | 2005-08-19 | 2007-06-12 | 한국과학기술원 | Microorganisms Transformed with Gene Encoding Fumarate Hydratase C and Method for Preparing Succinic Acid Using the Same |
| CN101300356A (en) * | 2005-09-09 | 2008-11-05 | 基因组股份公司 | Methods and organisms for the growth-coupled production of succinate |
| KR100762962B1 (en) | 2006-05-04 | 2007-10-04 | 한국과학기술원 | Method for preparing culture media using genome information and in silico analysis |
| KR100780324B1 (en) | 2006-07-28 | 2007-11-29 | 한국과학기술원 | Novel engineered microorganism producing homo-succinic acid and method for preparing succinic acid using the same |
| KR101103839B1 (en) * | 2007-07-12 | 2012-01-06 | 한국과학기술원 | Homo-Succinic Acid Producing Microorganism Variant and Process for Preparing Succinic Acid Using the Same |
| CN103589662A (en) | 2007-08-17 | 2014-02-19 | 巴斯夫欧洲公司 | Carboxylic Acid Producing Member of the Pasteurellaceae |
| KR101221557B1 (en) | 2010-08-30 | 2013-01-14 | 한국과학기술원 | Novel Engineered Microorganism Producing Succinic Acid with High Yield by Utilizing Both Sucrose and Glycerol at the Same Time and Method for Preparing Succinic Acid Using the Same |
-
2006
- 2006-07-28 KR KR1020060071666A patent/KR100780324B1/en active IP Right Grant
-
2007
- 2007-07-25 PT PT77932408T patent/PT2054502E/en unknown
- 2007-07-25 EP EP07793240.8A patent/EP2054502B2/en active Active
- 2007-07-25 CN CN2007800360664A patent/CN101636488B/en active Active
- 2007-07-25 CA CA2659246A patent/CA2659246C/en active Active
- 2007-07-25 AU AU2007277593A patent/AU2007277593B2/en active Active
- 2007-07-25 MY MYPI20092744A patent/MY162581A/en unknown
- 2007-07-25 BR BRPI0713839-3A patent/BRPI0713839B1/en active IP Right Grant
- 2007-07-25 DK DK07793240.8T patent/DK2054502T4/en active
- 2007-07-25 WO PCT/KR2007/003574 patent/WO2008013405A1/en active Application Filing
- 2007-07-25 NZ NZ575237A patent/NZ575237A/en unknown
- 2007-07-25 JP JP2009522705A patent/JP5421103B2/en active Active
- 2007-07-25 RU RU2009107208/10A patent/RU2415942C2/en active
- 2007-07-25 MX MX2009001004A patent/MX2009001004A/en active IP Right Grant
- 2007-07-25 ES ES07793240.8T patent/ES2464159T5/en active Active
-
2009
- 2009-01-22 ZA ZA200901254A patent/ZA200901254B/en unknown
- 2009-01-25 US US12/359,322 patent/US9217138B2/en active Active
-
2015
- 2015-10-03 US US14/874,385 patent/US9428774B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US9428774B2 (en) | 2016-08-30 |
| US20090203095A1 (en) | 2009-08-13 |
| EP2054502B2 (en) | 2017-06-28 |
| US20160017383A1 (en) | 2016-01-21 |
| CN101636488B (en) | 2013-07-31 |
| AU2007277593B2 (en) | 2012-08-02 |
| ZA200901254B (en) | 2010-08-25 |
| DK2054502T4 (en) | 2017-09-04 |
| RU2415942C2 (en) | 2011-04-10 |
| CA2659246A1 (en) | 2008-01-31 |
| RU2009107208A (en) | 2010-09-10 |
| NZ575237A (en) | 2011-11-25 |
| US9217138B2 (en) | 2015-12-22 |
| WO2008013405A1 (en) | 2008-01-31 |
| PT2054502E (en) | 2014-07-09 |
| AU2007277593A1 (en) | 2008-01-31 |
| JP5421103B2 (en) | 2014-02-19 |
| BRPI0713839B1 (en) | 2017-07-04 |
| EP2054502A1 (en) | 2009-05-06 |
| ES2464159T3 (en) | 2014-05-30 |
| EP2054502B1 (en) | 2014-04-02 |
| ES2464159T5 (en) | 2017-10-27 |
| CN101636488A (en) | 2010-01-27 |
| KR100780324B1 (en) | 2007-11-29 |
| JP2009544335A (en) | 2009-12-17 |
| MY162581A (en) | 2017-06-30 |
| MX2009001004A (en) | 2009-05-25 |
| DK2054502T3 (en) | 2014-04-28 |
| EP2054502A4 (en) | 2009-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2659246C (en) | Novel engineered microorganism producing homo-succinic acid and method for preparing succinic acid using the same | |
| CN104254612B (en) | A kind of production method of 2,4- dihydroxy butyric acid | |
| CA2751280A1 (en) | Novel microbial succinic acid producers and purification of succinic acid | |
| JP2016518145A (en) | Recombinant E. coli and the use of recombinant E. coli to produce succinic acid | |
| JP2018134108A (en) | PRODUCTION OF ORGANIC ACIDS BY FERMENTATION AT LOW pH CONDITIONS | |
| CN109321590B (en) | Genetically engineered bacterium for producing L-lactic acid by using acetic acid and construction method and application thereof | |
| JP5805768B2 (en) | Novel succinic acid-producing mutant microorganism using sucrose and glycerol simultaneously, and method for producing succinic acid using the same | |
| JP6608392B2 (en) | Genetically modified microorganisms for improved production of fine chemicals in sucrose | |
| US8877482B2 (en) | Homo-succinic acid producing microorganism variant and process for preparing succinic acid using the same | |
| WO2011163128A1 (en) | Engineered bacteria produce succinate from sucrose | |
| US10287558B2 (en) | Microorganisms for succinic acid production | |
| MX2015004180A (en) | Recombinant microorganisms for producing organic acids. | |
| EP3102672A1 (en) | Modified microorganism for improved production of fine chemicals on sucrose | |
| JP6528295B1 (en) | Hydrogenophilus bacteria transformant | |
| JP7158107B2 (en) | Method for producing organic compounds | |
| WO2016030373A1 (en) | Modified microorganism for improved production of fine chemicals on sucrose |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |